Catalent reports Q1 loss, misses market expectations [Yahoo! Finance]
Catalent, Inc. (CTLT)
Last catalent, inc. earnings: 2/3 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
investor.catalent.com
Company Research
Source: Yahoo! Finance
The company posted a loss per share of $0.13, significantly worse than the earnings per share (EPS) of $0.03 that analysts expected. Revenue came in at $1.02 billion, also below the consensus estimate of $1.06 billion. “Our first quarter fiscal 2025 results reflect the continued momentum in our business and underscore our customers' continued confidence in Catalent. Financial highlights in the quarter included double-digit year-over-year growth in both non-COVID revenue and adjusted EBITDA, while also delivering positive free cash flow,” said Alessandro Maselli, President and CEO of Catalent. In its Biologics segment, Catalent saw net revenue rise 3.1% year-over-year to $461 million, though this figure lagged behind the expected $476.2 million. Meanwhile, Pharmaceuticals&Consumer Health achieved $563 million in net revenue, marking a 5.2% year-over-year increase, and also slightly under the forecast of $563.9 million. Catalent's adjusted EBITDA reached $125 million, represe
Show less
Read more
Impact Snapshot
Event Time:
CTLT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CTLT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CTLT alerts
High impacting Catalent, Inc. news events
Weekly update
A roundup of the hottest topics
CTLT
News
- Catalent (CTLT) Reports Q1 Loss, Lags Revenue Estimates [Yahoo! Finance]Yahoo! Finance
- Catalent, Inc. Reports First Quarter Fiscal 2025 ResultsBusiness Wire
- EU antitrust regulators to rule on Novo's Catalent buy by Dec. 6 [Yahoo! Finance]Yahoo! Finance
- Ardena Expands Bioanalytical Services in Europe [Yahoo! Finance]Yahoo! Finance
- Ardena Expands Bioanalytical Services in Europe [Financial Post (Toronto, Ontario, Canada)]Financial Post
CTLT
Earnings
- 8/29/24 - Miss
CTLT
Sec Filings
- 11/5/24 - Form 10-Q
- 11/5/24 - Form 8-K
- 11/1/24 - Form 4
- CTLT's page on the SEC website